Royalty Pharma Plc (RPRX) — Free Cash Flow Generation Index
Royalty Pharma Plc (RPRX) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $760.54 Million represents 1% of operating cash flow ($760.54 Million). Read Royalty Pharma Plc balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Royalty Pharma Plc Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Royalty Pharma Plc across 11 annual periods. Explore Royalty Pharma Plc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Royalty Pharma Plc (2002–2025)
Year-by-year Free Cash Flow Generation Index for Royalty Pharma Plc. For the full company profile including market capitalisation, see market cap of Royalty Pharma Plc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $2.49 Billion | $2.49 Billion | $0.00 | ▲ +0.0% |
| 2024 | 1.00x | $2.77 Billion | $2.77 Billion | $0.00 | ▲ +0.0% |
| 2023 | 1.00x | $2.99 Billion | $2.99 Billion | $2.12 Billion | ▼ -48.8% |
| 2022 | 1.95x | $4.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +95.2% |
| 2021 | 1.00x | $2.02 Billion | $2.02 Billion | $523.00K | ▼ -51.9% |
| 2020 | 2.08x | $4.23 Billion | $2.03 Billion | $2.20 Billion | ▲ +108.0% |
| 2019 | 1.00x | $1.67 Billion | $1.67 Billion | $1.72 Billion | ▲ +0.0% |
| 2018 | 1.00x | $1.62 Billion | $1.62 Billion | $269.59 Million | ▲ +0.0% |
| 2017 | 1.00x | $1.42 Billion | $1.42 Billion | $2.29 Billion | ▲ +0.0% |
| 2003 | 1.00x | $11.15 Million | $11.15 Million | $0.00 | ▼ -0.6% |
| 2002 | 1.01x | $8.49 Million | $8.45 Million | $49.00K | — |